Riskpilot← Back to searchSign inGet full accessDr Hercules AB
ABDissolvedOrg 5567586754General medical practice activities · NACE 8621Est. 20080 employees
Revenue 2018
SEK 398K
-88% vs 2017
EBITDA margin
46.7%
-86% vs 2017
Equity ratio
22.2%
Financial strength
Net profit 2018
SEK 0
-100% vs 2017
| Revenue | SEK 398K | -88% |
| EBITDA | SEK 186K | -86% |
| Net profit | SEK 0 | -100% |
| Total assets | SEK 4,5M | -22% |
| Equity | SEK 995K | +0% |
| Employees | 0 | — |
Legal name
Dr Hercules AB
Org number
5567586754
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
26 maj 2008
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2018-12-31
Financial year
January – December
Company purpose
Bolaget skall bedriva hälso- och sjukvårdsverksamhet, IT-relaterad verksamhetsutveckling samt äga, hyra ut och förvalta ändamålsenliga lokaler och annan fast egendom, samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 |
|---|---|---|---|
| Revenue | 1 032 | 3 375 | 398 |
| Staff expenses | — | — | — |
| EBITDA | 2 411 | 1 303 | 186 |
| Depreciation & amort. | −756 | — | — |
| EBIT | 1 655 | 1 303 | 186 |
| Net financials | −174 | −32 | −2 |
| Profit before tax | 414 | 626 | 0 |
| Tax | −91 | −138 | −0 |
| Net profit | 323 | 488 | 0 |
| Item | 2016 | 2017 | 2018 |
|---|---|---|---|
| Total assets | 5 346 | 5 751 | 4 478 |
| Equity | 507 | 995 | 995 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 3 104 | 2 375 | 692 |
| Total debt | 3 104 | 2 375 | 692 |
EBITDA margin
46.7%
This company
15.8%
Market median
+196% vs market
20162018
Equity ratio
22.2%
This company
38.2%
Market median
-42% vs market
20162018
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20162018
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20162018
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20162018
Debt / equity
3.50×
This company
0.62×
Market median
-465% vs market
20162018
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ÅM External Signatory | External Signatory | 2020 | — | — |
CF Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
JE External Signatory | External Signatory | 2020 | — | — |
NE Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Hercules AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Åsa Maria Lundskog | External Signatory | 0 companies |
| Carl Fredrik Gunmalm | Chief Executive Officer | 0 companies |
| John Erik Gustaf Rahmquist | External Signatory | 0 companies |
| Nina Elisabeth Bergman | Chief Auditor | 0 companies |
| Ulf Daniel Olsson | Chairman | 0 companies |
| Jarl Erik Martin Torstensson | Board of Directors | 0 companies |